Control of cyclin-dependent kinase inhibitor p27 expression by cap-independent translation

被引:81
|
作者
Miskimins, WK [1 ]
Wang, G [1 ]
Hawkinson, M [1 ]
Miskimins, R [1 ]
机构
[1] Univ S Dakota, Sch Med, Div Basic Biomed Sci, Vermillion, SD 57069 USA
关键词
D O I
10.1128/MCB.21.15.4960-4967.2001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p27 is a key regulator of cell proliferation through inhibition of G, cyclin-dependent kinase (CE)K) activity. Translation of the p27 mRNA is an important control mechanism for determining cellular Levels of the inhibitor. Nearly all eukaryotic mRNAs are translated through a mechanism involving recognition of the 5 ' cap by eukargotic initiation factor 4E (eIF4E), In quiescent cells eIF4E activity is repressed, leading to a global decline in translation rates. In contrast, p27 translation is highest during quiescence, suggesting that it escapes the general repression of translational initiation. We show that the 5 ' untranslated region (5 ' -UTR) of the p27 mRNA mediates cap-independent translation. This activity is unaffected by conditions in which eIF4E is inhibited. In D6P2T cells, elevated cyclic AMP levels cause a rapid withdrawal from the cell cycle that is correlated with a striking increase in p27, Under these same conditions, cap-independent translation from the p27 5 ' -UTR is enhanced. These results indicate that regulation of internal initiation of translation is an important determinant of p27 protein levels.
引用
收藏
页码:4960 / 4967
页数:8
相关论文
共 50 条
  • [21] Expression of cyclin-dependent kinase inhibitor, p27 in ductal carcinoma in situ and atypical ductal hyperplasia of breast
    Kohli, A
    Mohtasham, F
    Wuu, J
    Reale, F
    Khan, A
    MODERN PATHOLOGY, 1998, 11 (01) : 22A - 22A
  • [22] Expression and significance of cyclin D1, cyclin-dependent kinase 4 and cyclin-dependent kinase inhibitor P27 in patients with non-neoplastic epithelial disorders of the vulva
    Liu, Huamei
    Zhang, Fan
    Li, Zongheng
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 26 (01)
  • [23] Proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in normal and tumor cells
    Mercurio, C
    Fiore, F
    Goubin, F
    Loda, M
    Pagano, M
    Draetta, GF
    EUROPEAN JOURNAL OF CELL BIOLOGY, 1997, 72 : 93 - 93
  • [24] Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27(Kip1)
    Vlach, J
    Hennecke, S
    Amati, B
    EMBO JOURNAL, 1997, 16 (17): : 5334 - 5344
  • [25] Cloning and characterization of rat p27(Kip1), a cyclin-dependent kinase inhibitor
    Nomura, H
    Sawada, Y
    Fujinaga, K
    Ohtaki, S
    GENE, 1997, 191 (02) : 211 - 218
  • [26] Cyclin-dependent kinase inhibitor p27 as a prognostic biomarker and potential cancer therapeutic target
    Hershko, Dan D.
    FUTURE ONCOLOGY, 2010, 6 (12) : 1837 - 1847
  • [28] Characterization of the murine cyclin-dependent kinase inhibitor gene p27(Kip1)
    Kwon, TK
    Nagel, JE
    Buchholz, MA
    Nordin, AA
    GENE, 1996, 180 (1-2) : 113 - 120
  • [29] CLONING AND CHARACTERIZATION OF THE XENOPUS CYCLIN-DEPENDENT KINASE INHIBITOR P27(XIC1)
    SU, JY
    REMPEL, RE
    ERIKSON, E
    MALLER, JL
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (22) : 10187 - 10191
  • [30] Alteration of PTEN expression in endometrial carcinoma is associated with down-regulation of cyclin-dependent kinase inhibitor, p27
    An, HJ
    Lee, YH
    Cho, NH
    Shim, JY
    Kim, JY
    Lee, C
    Kim, SJ
    HISTOPATHOLOGY, 2002, 41 (05) : 437 - 445